Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,470,000 | 1,944,000 | 1,966,000 | 2,372,000 | 1,768,000 |
| Marketable Securities | 21,427,000 | 29,125,000 | 27,730,000 | 19,328,000 | 11,899,000 |
| Receivables | 13,225,000 | 11,479,000 | 11,897,000 | 10,587,000 | 9,864,000 |
| Inventories | 9,979,000 | 9,059,000 | 8,640,000 | 8,948,000 | 8,493,000 |
| Income taxes - deferred | 3,117,000 | 4,266,000 | N/A | N/A | N/A |
| Other current assets | 4,202,000 | 3,820,000 | 7,667,000 | 7,579,000 | 7,509,000 |
| TOTAL | $54,420,000 | $59,693,000 | $57,900,000 | $48,814,000 | $39,533,000 |
| Non-Current Assets | |||||
| PPE Net | 15,109,000 | 14,882,000 | 14,436,000 | 14,224,000 | 14,011,000 |
| Investments And Advances | 20,737,000 | 21,526,000 | 21,597,000 | 20,942,000 | 20,228,000 |
| Intangibles | 80,027,000 | 74,354,000 | 75,795,000 | 77,190,000 | 77,765,000 |
| Other Non-Current Assets | 13,547,000 | 11,020,000 | 9,460,000 | 8,750,000 | 7,281,000 |
| TOTAL | $129,420,000 | $121,782,000 | $121,288,000 | $121,106,000 | $119,285,000 |
| Total Assets | $183,841,000 | $181,476,000 | $179,188,000 | $169,920,000 | $158,818,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 645,000 | 2,241,000 | 3,629,000 | 3,888,000 | 4,352,000 |
| Accounts payable and accrued liabilities | 5,506,000 | 5,578,000 | 4,698,000 | 4,327,000 | 4,064,000 |
| Accrued Expenses | 2,249,000 | 3,332,000 | 2,571,000 | 2,015,000 | 1,985,000 |
| Other current liabilities | 24,583,000 | 24,939,000 | 20,690,000 | 17,217,000 | 12,798,000 |
| TOTAL | $39,268,000 | $42,671,000 | $41,803,000 | $35,664,000 | $26,652,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 35,656,000 | 36,195,000 | 36,250,000 | 35,354,000 | 35,347,000 |
| Deferred Revenues | 3,108,000 | 3,067,000 | 3,529,000 | 4,291,000 | 2,052,000 |
| aiOther Non-Current Liabilities | 25,570,000 | 24,800,000 | 24,828,000 | 24,400,000 | 23,588,000 |
| TOTAL | $61,887,000 | $61,342,000 | $61,418,000 | $63,941,000 | $63,299,000 |
| Total Liabilities | $101,155,000 | $104,013,000 | $103,221,000 | $99,605,000 | $89,953,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,610,896 | 5,623,347 | 5,612,867 | 5,606,688 | 5,597,694 |
| Common Shares | 476,000 | 473,000 | 473,000 | 472,000 | 472,000 |
| Retained earnings | 111,193,000 | 103,394,000 | 102,252,000 | 96,346,000 | 95,158,000 |
| Other shareholders' equity | -5,897,000 | -5,635,000 | -5,372,000 | -4,483,000 | -4,418,000 |
| TOTAL | $82,685,000 | $77,462,000 | $75,967,000 | $70,315,000 | $68,865,000 |
| Total Liabilities And Equity | $183,840,000 | $181,475,000 | $179,188,000 | $169,920,000 | $158,818,000 |